Scientist discovers why drug boosts memory in Down syndrome mice

November 24, 2011 in Medical research

(Medical Xpress) -- A University of Colorado School of Medicine researcher who found a drug that improved memory in mice with Down syndrome has unlocked the mystery of how it works.  

In a new study published in Learning & Memory, Alberto Costa, MD, Ph.D., Associate Professor of Medicine and Neuroscience, and Graduate Assistant Jonah Scott-McKean found the mechanism behind excessive levels of long-term synaptic depression, or LTD, in mice with .  LTD makes transmission of messages along the brain’s synapses more difficult and is frequently referred to as a mechanism for forgetting.

The study proposes that the excess LTD is likely caused by the overrepresentation of a limited subset of genes contained in the extra chromosome carried by these mouse models of Down syndrome.  The investigators also found that when the drug memantine was administered to these mice at doses similar to those used to treat Alzheimer’s disease, LTD levels fell significantly. Therefore, Costa and Scott-McKean hypothesize that similar phenomena might also occur in the brains of persons with Down syndrome. 

"We found the mechanism by which LTD is exaggerated in a mouse model of Down syndrome," Costa said. "We wanted to see if memantine would normalize the brain function of these mice. We found that the drug brings this important physiological parameter associated to learning and memory ice to near normal levels."

Costa found that this exaggerated LTD in Down syndrome mice does not share the same cellular mechanism as a similar phenomenon seen in a mouse that mimics the human disorder known as fragile X syndrome, which is the second most common form of intellectual disability of genetic origin.  Costa had earlier discovered that memantine, currently used to treat patients with Alzheimer’s disease, improved in with Down syndrome but exactly how was unclear. He recently completed the data collection phase of a clinical trial using the drug on about 40 people with Down syndrome. The results have not yet been published.

"This will help us develop rational therapies for different intellectual disabilities.  For example, based on these findings, it is probably unlikely that certain compounds that are currently being tested for the treatment of fragile X would work in persons with Down syndrome and, conversely, it is unlikely that a like memantine might be of any help in the improvement of cognition of young individuals with fragile X" he said. "It will also help us in the planning of clinical trials and represents another move toward more personalized therapies."

Provided by University of Colorado Denver

4.3 /5 (3 votes)  

Rank 4.3 /5 (3 votes)
Relevant PhysicsForums posts
  • Potential Breakthrough in Seizure Control
    created12 hours ago
  • Popping/Cracked sternum.
    created17 hours ago
  • Which Mental Illness Encompasses This Problem?
    created17 hours ago
  • A question about drug tolerance
    createdMay 23, 2012
  • Poor nutrition leading to overeating?
    createdMay 23, 2012
  • Math and dyslexia?
    createdMay 21, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Implantable pain disk may help those with cancer

An estimated 3.5 million cancer patients around the globe are in severe pain from their disease, but many get no relief.

Medical research created May 25, 2012 | popularity not rated yet | comments 0 | with audio podcast

Energy levels link sleep control mechanisms

Sleep, or lack of it, can determine level of cognitive performance which is linked with accidents as well as increased risk of serious health problems. Links between cell energy levels, gene transcription ...

Medical research created May 25, 2012 | popularity not rated yet | comments 0

Researchers identify key brain cell in antidepressant action

(Medical Xpress) -- Antidepressant medications such as Prozac have helped improve mood and lessen anxiety in millions of people with major depression. But scientists know surprisingly little about how these drugs work.

Medical research created May 25, 2012 | popularity 4.7 / 5 (3) | comments 0 | with audio podcast

Rockefeller scientists pioneer new method to determine mechanisms of drug action

(Medical Xpress) -- Knowing that a drug works is great. Knowing how it works is a luxury. And until now, determining a drug’s mechanism of action has been a tedious and difficult process for scientists.

Medical research created May 25, 2012 | popularity not rated yet | comments 0 | with audio podcast

Like curry? New biological role identified for compound used in ancient medicine

Scientists have just identified a new reason why some curry dishes, made with spices humans have used for thousands of years, might be good for you.

Medical research created May 25, 2012 | popularity 4.5 / 5 (12) | comments 2 | with audio podcast


Travel to high altitudes tied to Crohn's, colitis flare-ups

(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...

Family history of Alzheimer's affects functional connectivity

(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...

Transvaginal mesh op restores pelvic organ prolapse at price

(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...

Tongue analysis software uses ancient Chinese medicine to warn of disease

For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...

Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse

(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...

Weight struggles? Blame new neurons in your hypothalamus

New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...